Oncolytics Biotech Inc (ONCY)
1.04
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 16:00
1.04
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2022 | -15.68M |
September 30, 2022 | -0.1033M |
June 30, 2022 | -0.2595M |
March 31, 2022 | -0.2565M |
December 31, 2021 | -0.2281M |
September 30, 2021 | -0.1674M |
June 30, 2021 | -0.0171M |
March 31, 2021 | -0.0137M |
December 31, 2020 | -0.0216M |
September 30, 2020 | -0.0229M |
June 30, 2020 | -0.0109M |
March 31, 2020 | -0.0141M |
December 31, 2019 | -0.0082M |
September 30, 2019 | 0.0017M |
June 30, 2019 | -0.0281M |
March 31, 2019 | -0.0513M |
December 31, 2018 | -0.0829M |
September 30, 2018 | -0.1521M |
June 30, 2018 | -0.0208M |
March 31, 2018 | -0.0766M |
December 31, 2017 | 1.530M |
September 30, 2017 | 1.581M |
June 30, 2017 | 1.476M |
March 31, 2017 | 1.554M |
December 31, 2016 | -0.0388M |
Date | Value |
---|---|
September 30, 2016 | -0.0787M |
June 30, 2016 | -0.0859M |
March 31, 2016 | -0.0947M |
December 31, 2015 | -0.1078M |
September 30, 2015 | -0.0762M |
June 30, 2015 | -0.1701M |
March 31, 2015 | -0.1571M |
December 31, 2014 | -0.1656M |
September 30, 2014 | -0.1542M |
June 30, 2014 | -0.1466M |
March 31, 2014 | -0.2735M |
December 31, 2013 | -0.279M |
September 30, 2013 | -0.2796M |
June 30, 2013 | -0.2097M |
March 31, 2013 | -0.1418M |
December 31, 2012 | -0.1589M |
September 30, 2012 | -0.3234M |
June 30, 2012 | -0.3791M |
March 31, 2012 | 1.382M |
December 31, 2011 | 1.431M |
September 30, 2011 | 1.509M |
June 30, 2011 | -0.2728M |
March 31, 2011 | -2.012M |
December 31, 2010 | -2.00M |
September 30, 2010 | -3.572M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-15.68M
Minimum
Dec 2022
0.0017M
Maximum
Sep 2019
-1.122M
Average
-0.0229M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
Acasti Pharma Inc | -1.452M |
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1991M |
Xenon Pharmaceuticals Inc | -117.17M |